A carregar...
New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data
The assessment of the cardiovascular safety profile of any newly developed antihyperglycemic drug is mandatory before registration, as a meta-analysis raised alarm describing a significant increase in myocardial infarction with the thiazolidinedione rosiglitazone. The first results from completed ca...
Na minha lista:
| Publicado no: | Biomed Res Int |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5574229/ https://ncbi.nlm.nih.gov/pubmed/28894748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/1253425 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|